Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Organon & Co. (OGN)

Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX PR Newswire - Wed May 6, 1:27PM CDT

NEW YORK , May 6, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

XOMA : 41.75 (+0.60%)
RMAX : 9.63 (-1.73%)
HLX : 9.91 (-0.60%)
OGN : 13.31 (-0.15%)
Are OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders? PR Newswire - Mon May 4, 1:55PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

TBRG : 25.89 (unch)
OGN : 13.31 (-0.15%)
CYCN : 3.18 (-0.31%)
OGN
Organon (NYSE:OGN) Misses Q1 CY2026 Revenue Estimates StockStory - Thu Apr 30, 5:10PM CDT

Organon (NYSE:OGN) Misses Q1 CY2026 Revenue Estimates

OGN : 13.31 (-0.15%)
Organon: Q1 Earnings Snapshot AP - Thu Apr 30, 6:45AM CDT

Organon: Q1 Earnings Snapshot

OGN : 13.31 (-0.15%)
Organon Reports Results for the First Quarter Ended March 31, 2026 Business Wire - Thu Apr 30, 6:30AM CDT

First quarter 2026 revenue of $1.460 billion, down 4% as-reported and down 9% excluding the impact of foreign currency. First quarter 2026 diluted earnings per share of $0.55 and non-GAAP...

OGN : 13.31 (-0.15%)
European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe PR Newswire - Wed Apr 29, 9:00AM CDT

SHANGHAI , April 29, 2026 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY...

OGN : 13.31 (-0.15%)
Organon Cancels First Quarter Earnings Call Business Wire - Wed Apr 29, 6:30AM CDT

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has canceled its first quarter 2026 earnings...

OGN : 13.31 (-0.15%)
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe Business Wire - Wed Apr 29, 4:30AM CDT

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY ® (pertuzumab) 420 mg/14 mL...

OGN : 13.31 (-0.15%)
Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN Business Wire - Tue Apr 28, 11:36AM CDT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Organon & Co. ...

OGN : 13.31 (-0.15%)
Trader watches red candles on monitor by Atichat Wattanasin Stone via Shutterstock
Nasdaq Futures Plunge as AI Concerns Resurface, FOMC Meeting and Earnings in Focus Barchart - Tue Apr 28, 5:34AM CDT

June Nasdaq 100 E-Mini futures (NQM26) are trending down -1.24% this morning as concerns resurfaced over whether the massive amounts of investment in AI will ultimately pay off.

NVDA : 220.78 (+0.61%)
GOOGL : 387.35 (-0.33%)
NOVN.Z.IX : 115.650 (+1.45%)
AVGO : 419.30 (-2.13%)
SNDK : 1,452.02 (-6.17%)
KO : 80.03 (+1.74%)
BBBY : 4.69 (-4.29%)
ORCL : 186.83 (-3.62%)
RMBS : 130.28 (-3.14%)
TEL.O.DX : 157.700 (+1.64%)
BP-.LN : 546.600 (+1.41%)
TMUS : 193.30 (+1.28%)

Barchart Exclusives

Inflation Has Pushed this Dividend Aristocrat to 52-Week Lows. Why It’s Still Not Quite Time to Buy. Barchart - Tue May 12, 6:30PM CDT
McDonald's stock is trading near its 52-week lows and has a dividend yield of aroudn 2.7%. However, the stock does not look like a compelling buy yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.